產(chǎn)品目錄

規(guī)格	1mg 5mg 10mg 25mg
CAS	N/A
別名	H2N-Pro-Gly-Ala-Arg-Ile-Phe-Ser-Phe-Asp-Gly-Lys-Asp-Val-Leu-Arg-His-Pro-Thr-Trp-Pro-Gln-Lys-Ser-Val-Trp-His-Gly-Ser-Asp-Pro-Asn-NH2
化學(xué)名	N/A
分子式	C161H236N48O43
分子量	3531.9
溶解度	≥ 353.2mg/mL in DMSO
儲(chǔ)存條件	Store at -20°C
General tips	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition	Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request

產(chǎn)品描述：

Endostatin, a 20kDa C-terminal fragment of collagen XVIII, is a potent inhibitor of primary tumor growth and endothelial cell proliferation and migration.

Collagen XVIII is a recently reported member of a family of collagen-like proteins, referred to as the multiplexins, and is localized mainly in a perivascular position around blood vessels.

Recombinant endostatin potently inhibited angiogenesis, maintains metastases at low level and suppressed tumors, a reduction of over 150-fold. Endostatin showed no toxicity to mice, no evidence of drug resistance, and no regrowth of tumors. [2]

Endostatin and TNP-470 treatments inhibited atherosclerosis by 85% and 70%, respectively. Either treatment significantly inhibited plaque growth, but the degree of inhibition by endostatin was less than that by TNP-470. Significant inhibition of plaque growth by endostatin or TNP-470 was seen even when the treatment was delayed until 32 weeks, although the degree of inhibition was smaller. Both endostatin and TNP-470 are reversible inhibitors of endothelial cell proliferation and appear to exert few effects on quiescent nonproliferating endothelium. [1]

Endostatin administered continuously into the peritoneal cavity by a mini-osmotic pump is 50% more effective in tumor suppression than the same dose administered once a day i.p. Furthermore, we show that a 10-fold lower dose, when given continuously, will accomplish the same tumor suppression as a single dose given i.p daily. Finally, we show that only continuous dosing can achieve tumor regression with human soluble endostatin. Endostatin retains biological activity in the osmotic pump for at least 7 days. Importantly, the endostatin does not undergo any obvious proteolytic degradation within an i.p. implanted pump. Soluble recombinant mouse endostatin (derived from P. pastoris) has shown efficacy against a human renal carcinoma in mice when given i.p as a single bolus dose of 10 –20 mg/kg/day. However, only 30% of animals in the treated group demonstrated tumor regression. [3]

特別提醒：

1. 本產(chǎn)品僅供科研使用。請(qǐng)勿用于醫(yī)藥、臨床診斷或治療，食品及化妝品等用途。請(qǐng)勿存放于普通住宅區(qū)。

2. 為了您的安全和健康，請(qǐng)穿好實(shí)驗(yàn)服并佩戴一次性手套和口罩操作。

原創(chuàng)作者：上海莼試生物技術(shù)有限公司

在線咨詢

留言注意事項(xiàng)：

1.遵守中華人民共和國(guó)有關(guān)法律、法規(guī)，尊重網(wǎng)上道德，承擔(dān)一切因您的行為而直接或間接引起的法律責(zé)任。

2.請(qǐng)您真實(shí)的反映產(chǎn)品的情況,不要捏造、誣蔑、造謠。如對(duì)產(chǎn)品有任何疑問(wèn),也可以留言咨詢。

3.未經(jīng)本站同意，任何人不得利用本留言簿發(fā)布個(gè)人或團(tuán)體的具有廣告性質(zhì)的信息或類似言論。

您感興趣的產(chǎn)品*
您的單位*
聯(lián)系人*
聯(lián)系電話*
詳細(xì)地址*
常用郵箱*
請(qǐng)輸入您對(duì)我們的意見(jiàn)或建議*
驗(yàn)證碼*